Companies › Cheiron
Cheiron logo

Cheiron

Palo Alto, California, USA · founded 2024 · ≈23 employees · Software Publishers · cheiron.bio

Cheiron is a biopharma AI software company that focuses on drug development. It has created an AI-native operating system designed to streamline scientific, clinical, regulatory, and competitive-intelligence workflows. The platform integrates various data sources, including literature, clinical trials, and safety data, into a unified system, allowing life sciences teams to manage drug programs effectively. The core technology behind Cheiron is its proprietary Life Sciences Knowledge Graph, which supports a range of applications such as drug discovery, clinical research, and regulatory intelligence. The platform features workflow-native AI agents that deliver decision-ready outputs with traceability and scientific rigor. Cheiron targets biopharma teams, biotech founders, and research-driven startups, providing tools for intelligent document automation, literature review, and clinical trial planning. Founded in 2024 and based in Los Altos/Palo Alto, California, Cheiron aims to unify the fragmented workflows in the pharmaceutical and biotech sectors.

Also: software development · b2b · saas · information technology & services · computer software

Funding

0
Every round, secondary, debt facility or acquisition involving Cheiron that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in